This unit will enhance students' understanding of cardiovascular risk, and the cardiovascular complications that may occur in metabolic disease. It will facilitate increased confidence in the assessment, prevention and practical medical management of cardiovascular disease in its broadest sense. Epidemiology and pathophysiology of atherogenesis and cardiovascular disease, will be addressed followed by an intensive focus on characterisation and patient-centred management of common modifiable cardiovascular risk factors including hypertension, lipoprotein disorders, diabetes and liftestyle factors pertinent to cardiovascular health. Evidence based screening and diagnostic methods, lifestyle interventions, pharmacotherapy and non-invasive monitoring will be covered. This will be followed by a detailed exploration of large and small vessel disease and implications of metabolic disease for brain, kidney and heart function (including ischaemic cardiomyopathy, diabetic cardiomyopathy and hypertensive cardiomyopathy). Peripheral arterial and cerebrovascular disease, arrhythmogenic disturbances, sleep disorders and non-alcoholic fatty liver disease will all be considered. At the conclusion of this unit of study, students will be equipped with the knowledge and skills to assess and manage cardiovascular disease risk and have a comprehensive understanding of cardiovascular complications of metabolic disease.
Unit details and rules
This unit is intended for students who have experience in clinical care of patients and includes a significant Pharmacology component
|Available to study abroad and exchange students
|Jason Harmer, firstname.lastname@example.org